Adrian McKemey - 20 May 2025 Form 4 Insider Report for Certara, Inc. (CERT)

Reporting relationship: President, Drug Dev. Solutions
Issuer ticker: CERT
Reported as of: 20 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2025, 16:37:56 UTC
Prior SEC filing: 10 Mar 2025
Next SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Daniel Corcoran, as Attorney-in-Fact for Adrian McKemey

Key filing fact

Adrian McKemey filed Form 4 for Certara, Inc. (CERT) on 22 May 2025.

Key facts

This page summarizes Adrian McKemey's Form 4 filing for Certara, Inc. (CERT).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 22 May 2025, 16:37.

Change

Previous filing in this sequence was filed on 10 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002058990 Primary reporting owner

McKemey Adrian

Relationship: President, Drug Dev. Solutions
Address: C/O CERTARA, INC., 4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Signature: /s/ Daniel Corcoran, as Attorney-in-Fact for Adrian McKemey
Signature date: 22 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CERT transaction Derivative

Performance Stock Units

Award

Transaction value: $0
Shares: +48,820
Change %
Price: $0.000000
Shares after: 48,820
Date: 20 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 48,820
Exercise price
Footnotes: F1

CERT transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +32,547
Change %
Price: $0.000000
Shares after: 32,547
Date: 20 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,547
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Certara, Inc. ("Company") performance stock unit ("PSU") was granted on May 20, 2025, pursuant to the terms of the 2025 Long-Term Incentive Plan for Company executives approved by the Compensation Committee of the Company's Board of Directors, under the Certara 2020 Incentive Plan (the "2020 Incentive Plan"). Each PSU represents a conditional right to receive one share of Company common stock. The reporting person will be entitled to receive a number of shares between 0% and 200% of the target amount reported based on the Company's performance against certain total shareholder return thresholds through the period ending on March 31, 2028.

Footnote F2

Each restricted stock unit ("RSU") was granted on May 20, 2025, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2026, April 1, 2027, and April 1, 2028.